将强力霉素重新用于阿尔茨海默氏症的治疗:从纳米给药角度看面临的挑战

IF 3.7 Q2 IMMUNOLOGY
Mariana Conceição , Leonardo Delello Di Filippo , Jonatas Lobato Duarte , Fernando Pereira Beserra , Maria Palmira Daflon Gremião , Marlus Chorilli
{"title":"将强力霉素重新用于阿尔茨海默氏症的治疗:从纳米给药角度看面临的挑战","authors":"Mariana Conceição ,&nbsp;Leonardo Delello Di Filippo ,&nbsp;Jonatas Lobato Duarte ,&nbsp;Fernando Pereira Beserra ,&nbsp;Maria Palmira Daflon Gremião ,&nbsp;Marlus Chorilli","doi":"10.1016/j.bbih.2024.100894","DOIUrl":null,"url":null,"abstract":"<div><div>Drug repurposing, also known as drug repositioning, involves identifying new applications for drugs whose effects in a disease are already established. Doxycycline, a broad-spectrum antibiotic belonging to the tetracycline class, has demonstrated potential activity against neurodegenerative diseases like Alzheimer's and Parkinson's. However, despite its promise, the repurposed use of doxycycline encounters challenges in reaching the brain in adequate concentrations to exert its effects. To address this issue, nanostructured systems offer an innovative approach that can enhance brain targeting and the desired therapeutic outcomes. This review discusses the advances in doxycycline repurposing for Alzheimer's disease, presenting physicochemical and biological aspects that permeate doxycycline's repositioning and its application in nano-based delivery systems.</div></div>","PeriodicalId":72454,"journal":{"name":"Brain, behavior, & immunity - health","volume":"42 ","pages":"Article 100894"},"PeriodicalIF":3.7000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Repurposing doxycycline for Alzheimer's treatment: Challenges from a nano-based drug delivery perspective\",\"authors\":\"Mariana Conceição ,&nbsp;Leonardo Delello Di Filippo ,&nbsp;Jonatas Lobato Duarte ,&nbsp;Fernando Pereira Beserra ,&nbsp;Maria Palmira Daflon Gremião ,&nbsp;Marlus Chorilli\",\"doi\":\"10.1016/j.bbih.2024.100894\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Drug repurposing, also known as drug repositioning, involves identifying new applications for drugs whose effects in a disease are already established. Doxycycline, a broad-spectrum antibiotic belonging to the tetracycline class, has demonstrated potential activity against neurodegenerative diseases like Alzheimer's and Parkinson's. However, despite its promise, the repurposed use of doxycycline encounters challenges in reaching the brain in adequate concentrations to exert its effects. To address this issue, nanostructured systems offer an innovative approach that can enhance brain targeting and the desired therapeutic outcomes. This review discusses the advances in doxycycline repurposing for Alzheimer's disease, presenting physicochemical and biological aspects that permeate doxycycline's repositioning and its application in nano-based delivery systems.</div></div>\",\"PeriodicalId\":72454,\"journal\":{\"name\":\"Brain, behavior, & immunity - health\",\"volume\":\"42 \",\"pages\":\"Article 100894\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2024-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brain, behavior, & immunity - health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666354624001728\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain, behavior, & immunity - health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666354624001728","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

药物再利用,又称药物重新定位,是指为那些对某种疾病已有疗效的药物确定新的应用领域。强力霉素是一种属于四环素类的广谱抗生素,已被证明对阿尔茨海默氏症和帕金森氏症等神经退行性疾病具有潜在活性。然而,尽管多西环素大有可为,但其再利用在以足够的浓度进入大脑以发挥其作用方面却遇到了挑战。为解决这一问题,纳米结构系统提供了一种创新方法,可增强大脑靶向性并达到预期的治疗效果。本综述讨论了强力霉素重新用于阿尔茨海默病的进展,介绍了渗透到强力霉素重新定位及其在纳米给药系统中应用的物理化学和生物学方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Repurposing doxycycline for Alzheimer's treatment: Challenges from a nano-based drug delivery perspective

Repurposing doxycycline for Alzheimer's treatment: Challenges from a nano-based drug delivery perspective
Drug repurposing, also known as drug repositioning, involves identifying new applications for drugs whose effects in a disease are already established. Doxycycline, a broad-spectrum antibiotic belonging to the tetracycline class, has demonstrated potential activity against neurodegenerative diseases like Alzheimer's and Parkinson's. However, despite its promise, the repurposed use of doxycycline encounters challenges in reaching the brain in adequate concentrations to exert its effects. To address this issue, nanostructured systems offer an innovative approach that can enhance brain targeting and the desired therapeutic outcomes. This review discusses the advances in doxycycline repurposing for Alzheimer's disease, presenting physicochemical and biological aspects that permeate doxycycline's repositioning and its application in nano-based delivery systems.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Brain, behavior, & immunity - health
Brain, behavior, & immunity - health Biological Psychiatry, Behavioral Neuroscience
CiteScore
8.50
自引率
0.00%
发文量
0
审稿时长
97 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信